These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31182086)

  • 1. Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.
    Malinka T; Nebrig M; Klein F; Pratschke J; Bahra M; Andreou A
    BMC Surg; 2019 Jun; 19(1):61. PubMed ID: 31182086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience.
    Zhao S; Zhou J; Li R; Sun L; Sun Q; Wang W; Wang D
    Langenbecks Arch Surg; 2024 Jul; 409(1):216. PubMed ID: 39008130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
    Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
    Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution.
    Blair AB; Reames BN; Singh J; Gani F; Overton HN; Beaulieu RJ; Lum YW; Black JH; Johnston FM; Ahuja N
    J Surg Oncol; 2018 Jul; 118(1):127-137. PubMed ID: 29878363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?
    Klooster B; Rajeev R; Chrabaszcz S; Charlson J; Miura J; Bedi M; Gamblin TC; Johnston F; Turaga KK
    J Surg Oncol; 2016 Jun; 113(7):823-7. PubMed ID: 27060344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.
    MacNeill AJ; Gronchi A; Miceli R; Bonvalot S; Swallow CJ; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Barretta F; Raut CP; Strauss DC
    Ann Surg; 2018 May; 267(5):959-964. PubMed ID: 28394870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
    Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Surgical Treatment as the Mainstay of Management in Retroperitoneal Sarcomas: Retrospective Study from Two Non-sarcoma Specialist Centers.
    Petrou A; Constantinidou A; Kontos M; Papalampros A; Moris D; Bakoyiannis C; Neofytou K; Kourounis G; Felekouras E
    Anticancer Res; 2017 Apr; 37(4):2025-2031. PubMed ID: 28373477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
    Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
    Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
    Nathan H; Raut CP; Thornton K; Herman JM; Ahuja N; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 Dec; 250(6):970-6. PubMed ID: 19644351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
    Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
    J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Méeus P; Stoeckle E; Riou O; Isambert N; Bompas E; Jafari M; Delcambre-Lair C; Saada E; Le Cesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):735-742. PubMed ID: 24567518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma.
    Glasbey JC; Bundred J; Tyler R; Hunt J; Tattersall H; Gourevitch D; Almond LM; Desai AD; Ford SJ
    Eur J Surg Oncol; 2021 Jul; 47(7):1771-1777. PubMed ID: 33549374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.